KYG7S53R1049 - Common Stock
PROKIDNEY CORP
NASDAQ:PROK (9/27/2023, 7:00:01 PM)
After market: 4.66 +0.34 (+7.87%)4.32
0 (0%)
ProKidney Corp. is a clinical-stage biotechnology company, which engages in the development of proprietary cell therapy platform. The company is headquartered in Winston-Salem, North Carolina and currently employs 87 full-time employees. The company went IPO on 2021-06-30. The firm is focused on cell therapy platforms capable of treating multiple chronic kidney diseases (CKD) using a patient’s own cells isolated from the patient intended for treatment. The Company’s lead product candidate, Renal Autologous Cell Therapy (REACT), is designed to preserve kidney function in a CKD patient’s diseased kidneys. REACT is a product that includes autologous Selected Renal Cells (SRCs) prepared from a patient’s own (autologous) kidney cells. The REACT injection is an investigational therapy that is a mixture of kidney cells prepared from the participant’s own kidney tissue. Its patented technology includes multiple breakthroughs in the manufacturing and medical delivery of cellular therapy products. The company is conducting a global Phase 3 development program and multiple Phase 2 clinical trials for REACT in subjects with moderate to severe diabetic kidney disease.
PROKIDNEY CORP
2000 Frontis Plaza Blvd., Suite 250
Winston-Salem NORTH CAROLINA
P: 13369997028.0
Employees: 87
Website: https://prokidney.com/
Chamath Palihapitiya, a 10% owner of ProKidney (PROK), sells 1.7 million shares for $9.3 million. He now owns 2,073,000 shares. Limited recent trading activity.
Wondering how the US markets performed one hour before the close of the markets on Tuesday? Discover the movers and shakers of today's session in our comprehensive analysis.
WINSTON-SALEM, N.C., Sept. 05, 2023 (GLOBE NEWSWIRE) -- ProKidney Corp. (Nasdaq: PROK) (“ProKidney” or the “Company”), a leading late clinical-stage...
These are the biotech short squeeze candidates to buy and hold for a massive rally of up to 100% in the coming quarters.
Here you can normally see the latest stock twits on PROK, but your cookie settings prevent this from loading. You can edit your cookie settings in our cookie consent dialog.
Example Twits: